No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2015/09/10 | Phase 1 | Completed | Hanmi Pharmaceutical Company Limited |
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|---|---|---|---|---|---|---|---|
EMEA/H/C/004120 | Czech Republic | Generic | Authorised | 2016/09/15 | 2016/07/21 | 15 | ||
EMEA/H/C/004137 | Czech Republic | Generic | Authorised | 2016/11/09 | 2016/09/15 | 10 | ||
EMEA/H/C/004250 | Czech Republic | Generic | Authorised | 2017/07/17 | 2017/05/18 | 12 |
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|
No NMPA products found for this drug
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|---|---|---|---|---|
269193 | Active | 2017/01/30 | tenofovir disoproxil phosphate | ||
269197 | Active | 2017/01/31 | tenofovir disoproxil phosphate | ||
269194 | Active | 2017/01/30 | tenofovir disoproxil phosphate |